Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | APLNR | P35414 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13313799 | 0.91 | CYP2D6 (0.36) | CYP2D6KDM4E | |
| SCHEMBL13313800 | 0.91 | CYP2D6 (0.40) | CYP2D6APLNR | |
| SCHEMBL13313798 | 0.86 | CYP2D6 (0.40) | CYP2D6KDM4E | |
| SCHEMBL13367601 | 0.84 | — | — | |
| SCHEMBL26176593 | 0.84 | — | — | |
| SCHEMBL12860105 | 0.84 | — | — | |
| SCHEMBL5044748 | 0.84 | — | — | |
| SCHEMBL23437396 | 0.79 | — | — | |
| SCHEMBL13480297 | 0.79 | — | — | |
| SCHEMBL12306213 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7737107-B2 | Trimethylcyclododecatriene derivatives, use thereof and perfumed products containing the same | Fils, V. Mane (FR) | 2010-06-15 | — | — | US | disclosed |
| US-20080139446-A1 | Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same | V. MANE FILS (FR) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139446-A1 | Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same | CBR3, C5, OXER1 | CYP2D6 297/4885KDM4E 1380/4885APLNR 3081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.